-+ 0.00%
-+ 0.00%
-+ 0.00%

EVOMMUNE SLIDES 18.1% PREMARKET AFTER CO'S ECZEMA DRUG MISSES MAIN GOAL IN MID-STAGE TRIAL

路透·09/09/2026 08:05:44

登录查看新闻详情